The subrenal capsule tumor implant assay as a predictor of clinical response to chemotherapy: 3 Years of experience
- 1 November 1984
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 19 (3) , 336-347
- https://doi.org/10.1016/0090-8258(84)90201-4
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Factors that influence growth of head and neck squamous carcinoma in the soft agar cloning assayCancer, 1984
- Chemosensitivity testing of human solid tumors. A review of 1582 assays with 258 clinical correlationsCancer, 1984
- Chemosensitivity testing of nonsolid tumors by the subrenal-capsule implant assayGynecologic Oncology, 1984
- Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapyCancer, 1983
- The james ewing lecture. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancerCancer, 1983
- Responsiveness of gynecologic tumors to chemotherapeutic agents in the 6-day subrenal capsule assayGynecologic Oncology, 1982
- Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapyThe American Journal of Medicine, 1981
- Reporting results of cancer treatmentCancer, 1981
- Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer DrugsNew England Journal of Medicine, 1978
- Primary Bioassay of Human Tumor Stem CellsScience, 1977